Expanding Horizons
Authorised Representation for Global Manufacturers
The company was founded in 1990 by David Thaler with the vision of providing sales and marketing services to European markets for foreign medical device manufacturers. Today, the company has expanded its network of manufacturers and suppliers as well as its portfolio in response to the market needs: Since 2005, MedNet EC-REP as a subsidiary of MedNet, provides the Authorised Representation Services for manufacturers located outside of Europe to sell their products on the European, British and Swiss market.
Philosophy
MedNet is a leading service provider to the healthcare industry. Our Representation Services enable manufacturers ouside of Europe to place their products on the European, British and Swiss market.
Against the background of an increasingly ageing population, and not at least due to strict European regulations we play a crucial role in supporting complainance and sustainability to our customers presence on European, British and Swiss market.
Principles
MedNet provides solutions for the future of healthcare. Through our customers, we ensure the continued marketing of products and thus a sustainable supply of the market.
Aiming for market leadership for European representation, we support our customers in meeting the demands of current regulations and represent their interests to the authorities, always with the focus to help our partners grow their business.
Sustainability
Because we think in terms of generations, sustainable management is a matter of concern to us. We want the resources we use to have the opportunity to regenerate or even grow.
We want to give something back to the environment. In doing so, we focus on the environment, our services to customers and our employees.
Can we assist you?
Put all your regulatory needs in our hands:
Our expert team of scientists and engineers are well equipped to understand your needs.
Latest News
Deadline Alert: Submission Requirements for MDR Conformity Assessment
Important updates regarding the extended transition period for certain medical devices under Regulation (EU) 2023/607.
Read more-1024x576.jpg&w=2048&q=75)
Key Changes in MDCG 2022-4 Rev 2 for Medical Device Manufacturers
The European Commission has issued the revised MDCG 2022-4 guidance, focusing on appropriate surveillance during the transition from the MDR
Read more